SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '3v76'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1CRB_A_RTLA200_0 (CELLULAR RETINOL BINDING PROTEIN)	3v76	FLAVOPROTEIN (Sinorhizobium meliloti)	5 / 12	PHE A 365 LEU A 184 ALA A 357 ILE A 133 ARG A 138	None	1.14A	1crbA-3v76A: undetectable	1crbA-3v76A: 15.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1HTT_C_HISC450_0 (HISTIDYL-TRNA SYNTHETASE)	3v76	FLAVOPROTEIN (Sinorhizobium meliloti)	5 / 12	GLU A 368 THR A 341 TYR A 176 GLY A 173 ALA A 171	FDA A 547 (-4.1A) None None None None	1.23A	1httC-3v76A: undetectable	1httC-3v76A: 22.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1HTT_D_HISD450_0 (HISTIDYL-TRNA SYNTHETASE)	3v76	FLAVOPROTEIN (Sinorhizobium meliloti)	5 / 12	GLU A 368 THR A 341 TYR A 176 GLY A 173 ALA A 171	FDA A 547 (-4.1A) None None None None	1.25A	1httD-3v76A: undetectable	1httD-3v76A: 22.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1SG9_C_SAMC303_0 (HEMK PROTEIN)	3v76	FLAVOPROTEIN (Sinorhizobium meliloti)	5 / 12	ILE A 11 GLY A 162 ALA A 171 VAL A 366 ALA A 15	None FDA A 547 (-3.4A) None None FDA A 547 (-3.9A)	1.09A	1sg9C-3v76A: 3.5	1sg9C-3v76A: 21.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1USQ_A_CLMA1143_0 (DR HEMAGGLUTININ STRUCTURAL SUBUNIT)	3v76	FLAVOPROTEIN (Sinorhizobium meliloti)	4 / 7	PRO A 40 GLY A 14 ILE A 10 GLY A 12	None FDA A 547 (-3.4A) None FDA A 547 (-3.4A)	0.80A	1usqA-3v76A: undetectable	1usqA-3v76A: 18.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1USQ_B_CLMB1143_0 (DR HEMAGGLUTININ STRUCTURAL SUBUNIT)	3v76	FLAVOPROTEIN (Sinorhizobium meliloti)	4 / 6	PRO A 40 GLY A 14 ILE A 10 GLY A 12	None FDA A 547 (-3.4A) None FDA A 547 (-3.4A)	0.78A	1usqB-3v76A: undetectable	1usqB-3v76A: 18.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1USQ_C_CLMC1143_0 (DR HEMAGGLUTININ STRUCTURAL SUBUNIT)	3v76	FLAVOPROTEIN (Sinorhizobium meliloti)	4 / 6	PRO A 40 GLY A 14 ILE A 10 GLY A 12	None FDA A 547 (-3.4A) None FDA A 547 (-3.4A)	0.81A	1usqC-3v76A: undetectable	1usqC-3v76A: 18.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1USQ_D_CLMD1142_0 (DR HEMAGGLUTININ STRUCTURAL SUBUNIT)	3v76	FLAVOPROTEIN (Sinorhizobium meliloti)	4 / 6	PRO A 40 GLY A 14 ILE A 10 GLY A 12	None FDA A 547 (-3.4A) None FDA A 547 (-3.4A)	0.78A	1usqD-3v76A: undetectable	1usqD-3v76A: 18.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1USQ_E_CLME1143_0 (DR HEMAGGLUTININ STRUCTURAL SUBUNIT)	3v76	FLAVOPROTEIN (Sinorhizobium meliloti)	4 / 6	PRO A 40 GLY A 14 ILE A 10 GLY A 12	None FDA A 547 (-3.4A) None FDA A 547 (-3.4A)	0.77A	1usqE-3v76A: undetectable	1usqE-3v76A: 18.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1USQ_F_CLMF1144_0 (DR HEMAGGLUTININ STRUCTURAL SUBUNIT)	3v76	FLAVOPROTEIN (Sinorhizobium meliloti)	4 / 7	PRO A 40 GLY A 14 ILE A 10 GLY A 12	None FDA A 547 (-3.4A) None FDA A 547 (-3.4A)	0.77A	1usqF-3v76A: undetectable	1usqF-3v76A: 18.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1W76_A_GNTA1538_1 (ACETYLCHOLINESTERASE)	3v76	FLAVOPROTEIN (Sinorhizobium meliloti)	5 / 11	ASP A 106 GLY A 50 GLY A 49 SER A 47 PHE A 54	None None None FDA A 547 (-4.4A) None	1.33A	1w76A-3v76A: undetectable	1w76A-3v76A: 21.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2F16_V_BO2V1401_1 (PROTEASOME COMPONENT PUP1 PROTEASOME COMPONENT PUP3)	3v76	FLAVOPROTEIN (Sinorhizobium meliloti)	5 / 11	THR A 131 ALA A 149 GLY A 150 THR A 151 ASP A 153	None	1.19A	2f16V-3v76A: undetectable 2f16W-3v76A: undetectable	2f16V-3v76A: 19.76 2f16W-3v76A: 19.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2JAP_B_J01B1249_1 (CLAVALDEHYDE DEHYDROGENASE)	3v76	FLAVOPROTEIN (Sinorhizobium meliloti)	5 / 12	LEU A 258 ILE A 254 ALA A 218 VAL A 229 ALA A 216	None	1.26A	2japB-3v76A: 2.5	2japB-3v76A: 22.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2JKJ_A_CLMA1141_0 (DR HEMAGGLUTININ STRUCTURAL SUBUNIT)	3v76	FLAVOPROTEIN (Sinorhizobium meliloti)	4 / 6	PRO A 40 GLY A 14 ILE A 10 GLY A 12	None FDA A 547 (-3.4A) None FDA A 547 (-3.4A)	0.76A	2jkjA-3v76A: undetectable	2jkjA-3v76A: 18.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2JKJ_B_CLMB1141_0 (DR HEMAGGLUTININ STRUCTURAL SUBUNIT)	3v76	FLAVOPROTEIN (Sinorhizobium meliloti)	4 / 6	PRO A 40 GLY A 14 ILE A 10 GLY A 12	None FDA A 547 (-3.4A) None FDA A 547 (-3.4A)	0.75A	2jkjB-3v76A: undetectable	2jkjB-3v76A: 18.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2JKJ_C_CLMC1141_0 (DR HEMAGGLUTININ STRUCTURAL SUBUNIT)	3v76	FLAVOPROTEIN (Sinorhizobium meliloti)	4 / 6	PRO A 40 GLY A 14 ILE A 10 GLY A 12	None FDA A 547 (-3.4A) None FDA A 547 (-3.4A)	0.76A	2jkjC-3v76A: undetectable	2jkjC-3v76A: 18.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2JKJ_E_CLME1141_0 (DR HEMAGGLUTININ STRUCTURAL SUBUNIT)	3v76	FLAVOPROTEIN (Sinorhizobium meliloti)	4 / 7	PRO A 40 GLY A 14 ILE A 10 GLY A 12	None FDA A 547 (-3.4A) None FDA A 547 (-3.4A)	0.74A	2jkjE-3v76A: undetectable	2jkjE-3v76A: 18.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2JKL_A_CLMA1144_0 (DR HEMAGGLUTININ STRUCTURAL SUBUNIT)	3v76	FLAVOPROTEIN (Sinorhizobium meliloti)	4 / 7	PRO A 40 GLY A 14 ILE A 10 GLY A 12	None FDA A 547 (-3.4A) None FDA A 547 (-3.4A)	0.78A	2jklA-3v76A: undetectable	2jklA-3v76A: 18.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2JKL_B_CLMB1144_0 (DR HEMAGGLUTININ STRUCTURAL SUBUNIT)	3v76	FLAVOPROTEIN (Sinorhizobium meliloti)	4 / 6	PRO A 40 GLY A 14 ILE A 10 GLY A 12	None FDA A 547 (-3.4A) None FDA A 547 (-3.4A)	0.79A	2jklB-3v76A: undetectable	2jklB-3v76A: 18.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2JKL_C_CLMC1143_0 (DR HEMAGGLUTININ STRUCTURAL SUBUNIT)	3v76	FLAVOPROTEIN (Sinorhizobium meliloti)	4 / 7	PRO A 40 GLY A 14 ILE A 10 GLY A 12	None FDA A 547 (-3.4A) None FDA A 547 (-3.4A)	0.81A	2jklC-3v76A: undetectable	2jklC-3v76A: 18.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2JKL_D_CLMD1145_0 (DR HEMAGGLUTININ STRUCTURAL SUBUNIT)	3v76	FLAVOPROTEIN (Sinorhizobium meliloti)	4 / 7	PRO A 40 GLY A 14 ILE A 10 GLY A 12	None FDA A 547 (-3.4A) None FDA A 547 (-3.4A)	0.79A	2jklD-3v76A: undetectable	2jklD-3v76A: 18.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2JKL_E_CLME1143_0 (DR HEMAGGLUTININ STRUCTURAL SUBUNIT)	3v76	FLAVOPROTEIN (Sinorhizobium meliloti)	4 / 7	PRO A 40 GLY A 14 ILE A 10 GLY A 12	None FDA A 547 (-3.4A) None FDA A 547 (-3.4A)	0.78A	2jklE-3v76A: undetectable	2jklE-3v76A: 18.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2JKL_F_CLMF1143_0 (DR HEMAGGLUTININ STRUCTURAL SUBUNIT)	3v76	FLAVOPROTEIN (Sinorhizobium meliloti)	4 / 7	PRO A 40 GLY A 14 ILE A 10 GLY A 12	None FDA A 547 (-3.4A) None FDA A 547 (-3.4A)	0.79A	2jklF-3v76A: undetectable	2jklF-3v76A: 18.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2V0M_B_KLNB1498_1 (CYTOCHROME P450 3A4)	3v76	FLAVOPROTEIN (Sinorhizobium meliloti)	5 / 9	LEU A 193 ALA A 240 GLU A 252 GLY A 331 LEU A 196	None	1.13A	2v0mB-3v76A: undetectable	2v0mB-3v76A: 21.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2YVL_A_SAMA601_0 (HYPOTHETICAL PROTEIN)	3v76	FLAVOPROTEIN (Sinorhizobium meliloti)	5 / 12	GLY A 414 GLY A 410 SER A 409 ALA A 75 ALA A 21	None	0.94A	2yvlA-3v76A: 3.1	2yvlA-3v76A: 21.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2ZIF_A_SAMA298_0 (PUTATIVE MODIFICATION METHYLASE)	3v76	FLAVOPROTEIN (Sinorhizobium meliloti)	5 / 12	ALA A 406 PRO A 167 GLY A 163 THR A 172 GLU A 368	FDA A 547 ( 3.7A) None None FDA A 547 (-3.1A) FDA A 547 (-4.1A)	1.20A	2zifA-3v76A: undetectable	2zifA-3v76A: 22.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3CKK_A_SAMA301_0 (TRNA (GUANINE-N(7)-)-METH YLTRANSFERASE)	3v76	FLAVOPROTEIN (Sinorhizobium meliloti)	5 / 12	GLY A 162 GLY A 163 GLU A 368 ALA A 16 LEU A 174	FDA A 547 (-3.4A) None FDA A 547 (-4.1A) FDA A 547 (-3.5A) FDA A 547 (-3.8A)	1.14A	3ckkA-3v76A: 2.5	3ckkA-3v76A: 20.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3JB1_A_SAMA1101_0 (STRUCTURAL PROTEIN VP3)	3v76	FLAVOPROTEIN (Sinorhizobium meliloti)	5 / 12	ILE A 11 GLY A 12 ASP A 35 ALA A 37 ALA A 16	None FDA A 547 (-3.4A) FDA A 547 (-3.1A) FDA A 547 ( 3.9A) FDA A 547 (-3.5A)	0.98A	3jb1A-3v76A: undetectable	3jb1A-3v76A: 17.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3MG0_H_BO2H1400_1 (PROTEASOME COMPONENT PUP1 PROTEASOME COMPONENT PUP3)	3v76	FLAVOPROTEIN (Sinorhizobium meliloti)	5 / 11	THR A 131 ALA A 149 GLY A 150 THR A 151 ASP A 153	None	1.14A	3mg0H-3v76A: undetectable 3mg0I-3v76A: undetectable	3mg0H-3v76A: 19.76 3mg0I-3v76A: 19.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3Q70_A_RITA2001_2 (CANDIDAPEPSIN-2)	3v76	FLAVOPROTEIN (Sinorhizobium meliloti)	4 / 6	THR A 341 SER A 161 ILE A 178 THR A 373	None FDA A 547 (-4.8A) None None	1.09A	3q70A-3v76A: undetectable	3q70A-3v76A: 21.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3QXY_A_SAMA6734_0 (N-LYSINE METHYLTRANSFERASE SETD6)	3v76	FLAVOPROTEIN (Sinorhizobium meliloti)	5 / 12	VAL A 159 ALA A 160 GLY A 12 ALA A 24 LEU A 363	None None FDA A 547 (-3.4A) None None	1.11A	3qxyA-3v76A: undetectable	3qxyA-3v76A: 23.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3RC0_A_SAMA484_0 (N-LYSINE METHYLTRANSFERASE SETD6)	3v76	FLAVOPROTEIN (Sinorhizobium meliloti)	5 / 11	VAL A 159 ALA A 160 GLY A 12 ALA A 24 LEU A 363	None None FDA A 547 (-3.4A) None None	1.11A	3rc0A-3v76A: undetectable	3rc0A-3v76A: 23.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3RC0_B_SAMB480_0 (N-LYSINE METHYLTRANSFERASE SETD6)	3v76	FLAVOPROTEIN (Sinorhizobium meliloti)	5 / 12	VAL A 159 ALA A 160 GLY A 12 ALA A 24 LEU A 363	None None FDA A 547 (-3.4A) None None	1.12A	3rc0B-3v76A: undetectable	3rc0B-3v76A: 23.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3SUD_A_SUEA1201_1 (NS3 PROTEASE, NS4A PROTEIN)	3v76	FLAVOPROTEIN (Sinorhizobium meliloti)	6 / 12	GLY A 17 GLY A 367 ALA A 406 ALA A 408 ALA A 75 SER A 74	None FDA A 547 (-3.5A) FDA A 547 ( 3.7A) None None None	1.43A	3sudA-3v76A: undetectable	3sudA-3v76A: 20.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4DA7_A_AC2A301_1 (PURINE NUCLEOSIDE PHOSPHORYLASE DEOD-TYPE)	3v76	FLAVOPROTEIN (Sinorhizobium meliloti)	5 / 10	MET A 120 GLY A 410 ALA A 24 GLU A 23 VAL A 366	None	0.86A	4da7A-3v76A: undetectable	4da7A-3v76A: 22.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4F4D_A_CHDA505_0 (FERROCHELATASE, MITOCHONDRIAL)	3v76	FLAVOPROTEIN (Sinorhizobium meliloti)	4 / 7	MET A 19 ARG A 27 VAL A 417 MET A 355	None	1.37A	4f4dA-3v76A: undetectable	4f4dA-3v76A: 21.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVP_H_BO2H301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	3v76	FLAVOPROTEIN (Sinorhizobium meliloti)	5 / 12	THR A 131 ALA A 149 GLY A 150 THR A 151 ASP A 153	None	1.23A	4qvpH-3v76A: undetectable 4qvpI-3v76A: undetectable	4qvpH-3v76A: 20.00 4qvpI-3v76A: 19.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVP_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	3v76	FLAVOPROTEIN (Sinorhizobium meliloti)	5 / 12	THR A 131 ALA A 149 GLY A 150 THR A 151 ASP A 153	None	1.24A	4qvpV-3v76A: undetectable 4qvpW-3v76A: undetectable	4qvpV-3v76A: 20.00 4qvpW-3v76A: 19.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVY_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	3v76	FLAVOPROTEIN (Sinorhizobium meliloti)	5 / 12	THR A 131 ALA A 149 GLY A 150 THR A 151 ASP A 153	None	1.24A	4qvyV-3v76A: undetectable 4qvyW-3v76A: undetectable	4qvyV-3v76A: 20.00 4qvyW-3v76A: 19.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QW0_H_BO2H301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	3v76	FLAVOPROTEIN (Sinorhizobium meliloti)	5 / 11	THR A 131 ALA A 149 GLY A 150 THR A 151 ASP A 153	None	1.23A	4qw0H-3v76A: undetectable 4qw0I-3v76A: undetectable	4qw0H-3v76A: 20.00 4qw0I-3v76A: 19.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QW0_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	3v76	FLAVOPROTEIN (Sinorhizobium meliloti)	5 / 11	THR A 131 ALA A 149 GLY A 150 THR A 151 ASP A 153	None	1.22A	4qw0V-3v76A: undetectable 4qw0W-3v76A: undetectable	4qw0V-3v76A: 20.00 4qw0W-3v76A: 19.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QW1_H_BO2H301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	3v76	FLAVOPROTEIN (Sinorhizobium meliloti)	5 / 12	THR A 131 ALA A 149 GLY A 150 THR A 151 ASP A 153	None	1.23A	4qw1H-3v76A: undetectable 4qw1I-3v76A: undetectable	4qw1H-3v76A: 20.00 4qw1I-3v76A: 19.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QW1_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	3v76	FLAVOPROTEIN (Sinorhizobium meliloti)	5 / 12	THR A 131 ALA A 149 GLY A 150 THR A 151 ASP A 153	None	1.23A	4qw1V-3v76A: undetectable 4qw1W-3v76A: undetectable	4qw1V-3v76A: 20.00 4qw1W-3v76A: 19.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4V20_A_ACTA1444_0 (CELLOBIOHYDROLASE)	3v76	FLAVOPROTEIN (Sinorhizobium meliloti)	4 / 5	GLY A 163 THR A 341 GLY A 344 GLU A 368	None None None FDA A 547 (-4.1A)	1.18A	4v20A-3v76A: undetectable	4v20A-3v76A: 22.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4X30_A_T44A401_1 (THYROXINE-BINDING GLOBULIN)	3v76	FLAVOPROTEIN (Sinorhizobium meliloti)	5 / 9	ALA A 216 GLN A 202 LEU A 198 LEU A 256 LEU A 236	None	1.43A	4x30A-3v76A: undetectable	4x30A-3v76A: 21.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4X30_A_T44A401_1 (THYROXINE-BINDING GLOBULIN)	3v76	FLAVOPROTEIN (Sinorhizobium meliloti)	5 / 9	ALA A 240 GLN A 202 LEU A 198 LEU A 256 LEU A 236	None	1.30A	4x30A-3v76A: undetectable	4x30A-3v76A: 21.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5BXN_H_BO2H301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	3v76	FLAVOPROTEIN (Sinorhizobium meliloti)	5 / 11	THR A 131 ALA A 149 GLY A 150 THR A 151 ASP A 153	None	1.18A	5bxnH-3v76A: undetectable 5bxnI-3v76A: undetectable	5bxnH-3v76A: 21.12 5bxnI-3v76A: 19.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5BXN_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	3v76	FLAVOPROTEIN (Sinorhizobium meliloti)	5 / 11	THR A 131 ALA A 149 GLY A 150 THR A 151 ASP A 153	None	1.18A	5bxnV-3v76A: undetectable 5bxnW-3v76A: undetectable	5bxnV-3v76A: 21.12 5bxnW-3v76A: 19.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5CZ7_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	3v76	FLAVOPROTEIN (Sinorhizobium meliloti)	5 / 12	THR A 131 ALA A 149 GLY A 150 THR A 151 ASP A 153	None	1.23A	5cz7V-3v76A: undetectable 5cz7W-3v76A: undetectable	5cz7V-3v76A: 20.00 5cz7W-3v76A: 19.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5E3I_A_HISA502_0 (HISTIDINE--TRNA LIGASE)	3v76	FLAVOPROTEIN (Sinorhizobium meliloti)	5 / 12	GLU A 368 THR A 341 TYR A 176 GLY A 173 ALA A 171	FDA A 547 (-4.1A) None None None None	1.21A	5e3iA-3v76A: undetectable	5e3iA-3v76A: 24.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5E3I_B_HISB502_0 (HISTIDINE--TRNA LIGASE)	3v76	FLAVOPROTEIN (Sinorhizobium meliloti)	5 / 11	GLU A 368 THR A 341 TYR A 176 GLY A 173 ALA A 171	FDA A 547 (-4.1A) None None None None	1.23A	5e3iB-3v76A: undetectable	5e3iB-3v76A: 24.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5L5F_H_BO2H301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	3v76	FLAVOPROTEIN (Sinorhizobium meliloti)	5 / 12	THR A 131 ALA A 149 GLY A 150 THR A 151 ASP A 153	None	1.23A	5l5fH-3v76A: undetectable 5l5fI-3v76A: undetectable	5l5fH-3v76A: 20.00 5l5fI-3v76A: 19.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5L5F_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	3v76	FLAVOPROTEIN (Sinorhizobium meliloti)	5 / 12	THR A 131 ALA A 149 GLY A 150 THR A 151 ASP A 153	None	1.23A	5l5fV-3v76A: undetectable 5l5fW-3v76A: undetectable	5l5fV-3v76A: 20.00 5l5fW-3v76A: 19.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5L66_H_BO2H301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	3v76	FLAVOPROTEIN (Sinorhizobium meliloti)	5 / 12	THR A 131 ALA A 149 GLY A 150 THR A 151 ASP A 153	None	1.22A	5l66H-3v76A: undetectable 5l66I-3v76A: undetectable	5l66H-3v76A: 20.00 5l66I-3v76A: 19.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5L66_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	3v76	FLAVOPROTEIN (Sinorhizobium meliloti)	5 / 12	THR A 131 ALA A 149 GLY A 150 THR A 151 ASP A 153	None	1.23A	5l66V-3v76A: undetectable 5l66W-3v76A: undetectable	5l66V-3v76A: 20.00 5l66W-3v76A: 19.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6FOS_A_PQNA2001_1 (PHOTOSYSTEM I P700 CHLOROPHYLL A APOPROTEIN A1)	3v76	FLAVOPROTEIN (Sinorhizobium meliloti)	4 / 6	MET A 18 GLY A 12 ALA A 37 LEU A 129	None FDA A 547 (-3.4A) FDA A 547 ( 3.9A) None	1.06A	6fosA-3v76A: undetectable	6fosA-3v76A: 11.17

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1CRB_A_RTLA200_0","CELLULAR RETINOL BINDING PROTEIN","3v76","FLAVOPROTEIN","Sinorhizobium meliloti",5,"PHE A 365;LEU A 184;ALA A 357;ILE A 133;ARG A 138","None","1.14A","1crbA-3v76A:undetectable","1crbA-3v76A:15.67"],["1HTT_C_HISC450_0","HISTIDYL-TRNA SYNTHETASE","3v76","FLAVOPROTEIN","Sinorhizobium meliloti",5,"GLU A 368;THR A 341;TYR A 176;GLY A 173;ALA A 171","FDA A 547 (-4.1A);None;None;None;None","1.23A","1httC-3v76A:undetectable","1httC-3v76A:22.89"],["1HTT_D_HISD450_0","HISTIDYL-TRNA SYNTHETASE","3v76","FLAVOPROTEIN","Sinorhizobium meliloti",5,"GLU A 368;THR A 341;TYR A 176;GLY A 173;ALA A 171","FDA A 547 (-4.1A);None;None;None;None","1.25A","1httD-3v76A:undetectable","1httD-3v76A:22.89"],["1SG9_C_SAMC303_0","HEMK PROTEIN","3v76","FLAVOPROTEIN","Sinorhizobium meliloti",5,"ILE A  11;GLY A 162;ALA A 171;VAL A 366;ALA A  15","None;FDA A 547 (-3.4A);None;None;FDA A 547 (-3.9A)","1.09A","1sg9C-3v76A:3.5","1sg9C-3v76A:21.54"],["1USQ_A_CLMA1143_0","DR HEMAGGLUTININ STRUCTURAL SUBUNIT","3v76","FLAVOPROTEIN","Sinorhizobium meliloti",4,"PRO A  40;GLY A  14;ILE A  10;GLY A  12","None;FDA A 547 (-3.4A);None;FDA A 547 (-3.4A)","0.80A","1usqA-3v76A:undetectable","1usqA-3v76A:18.54"],["1USQ_B_CLMB1143_0","DR HEMAGGLUTININ STRUCTURAL SUBUNIT","3v76","FLAVOPROTEIN","Sinorhizobium meliloti",4,"PRO A  40;GLY A  14;ILE A  10;GLY A  12","None;FDA A 547 (-3.4A);None;FDA A 547 (-3.4A)","0.78A","1usqB-3v76A:undetectable","1usqB-3v76A:18.54"],["1USQ_C_CLMC1143_0","DR HEMAGGLUTININ STRUCTURAL SUBUNIT","3v76","FLAVOPROTEIN","Sinorhizobium meliloti",4,"PRO A  40;GLY A  14;ILE A  10;GLY A  12","None;FDA A 547 (-3.4A);None;FDA A 547 (-3.4A)","0.81A","1usqC-3v76A:undetectable","1usqC-3v76A:18.54"],["1USQ_D_CLMD1142_0","DR HEMAGGLUTININ STRUCTURAL SUBUNIT","3v76","FLAVOPROTEIN","Sinorhizobium meliloti",4,"PRO A  40;GLY A  14;ILE A  10;GLY A  12","None;FDA A 547 (-3.4A);None;FDA A 547 (-3.4A)","0.78A","1usqD-3v76A:undetectable","1usqD-3v76A:18.54"],["1USQ_E_CLME1143_0","DR HEMAGGLUTININ STRUCTURAL SUBUNIT","3v76","FLAVOPROTEIN","Sinorhizobium meliloti",4,"PRO A  40;GLY A  14;ILE A  10;GLY A  12","None;FDA A 547 (-3.4A);None;FDA A 547 (-3.4A)","0.77A","1usqE-3v76A:undetectable","1usqE-3v76A:18.54"],["1USQ_F_CLMF1144_0","DR HEMAGGLUTININ STRUCTURAL SUBUNIT","3v76","FLAVOPROTEIN","Sinorhizobium meliloti",4,"PRO A  40;GLY A  14;ILE A  10;GLY A  12","None;FDA A 547 (-3.4A);None;FDA A 547 (-3.4A)","0.77A","1usqF-3v76A:undetectable","1usqF-3v76A:18.54"],["1W76_A_GNTA1538_1","ACETYLCHOLINESTERASE","3v76","FLAVOPROTEIN","Sinorhizobium meliloti",5,"ASP A 106;GLY A  50;GLY A  49;SER A  47;PHE A  54","None;None;None;FDA A 547 (-4.4A);None","1.33A","1w76A-3v76A:undetectable","1w76A-3v76A:21.23"],["2F16_V_BO2V1401_1","PROTEASOME COMPONENT PUP1;PROTEASOME COMPONENT PUP3","3v76","FLAVOPROTEIN","Sinorhizobium meliloti",5,"THR A 131;ALA A 149;GLY A 150;THR A 151;ASP A 153","None","1.19A","2f16V-3v76A:undetectable;2f16W-3v76A:undetectable","2f16V-3v76A:19.76;2f16W-3v76A:19.52"],["2JAP_B_J01B1249_1","CLAVALDEHYDE DEHYDROGENASE","3v76","FLAVOPROTEIN","Sinorhizobium meliloti",5,"LEU A 258;ILE A 254;ALA A 218;VAL A 229;ALA A 216","None","1.26A","2japB-3v76A:2.5","2japB-3v76A:22.25"],["2JKJ_A_CLMA1141_0","DR HEMAGGLUTININ STRUCTURAL SUBUNIT","3v76","FLAVOPROTEIN","Sinorhizobium meliloti",4,"PRO A  40;GLY A  14;ILE A  10;GLY A  12","None;FDA A 547 (-3.4A);None;FDA A 547 (-3.4A)","0.76A","2jkjA-3v76A:undetectable","2jkjA-3v76A:18.54"],["2JKJ_B_CLMB1141_0","DR HEMAGGLUTININ STRUCTURAL SUBUNIT","3v76","FLAVOPROTEIN","Sinorhizobium meliloti",4,"PRO A  40;GLY A  14;ILE A  10;GLY A  12","None;FDA A 547 (-3.4A);None;FDA A 547 (-3.4A)","0.75A","2jkjB-3v76A:undetectable","2jkjB-3v76A:18.54"],["2JKJ_C_CLMC1141_0","DR HEMAGGLUTININ STRUCTURAL SUBUNIT","3v76","FLAVOPROTEIN","Sinorhizobium meliloti",4,"PRO A  40;GLY A  14;ILE A  10;GLY A  12","None;FDA A 547 (-3.4A);None;FDA A 547 (-3.4A)","0.76A","2jkjC-3v76A:undetectable","2jkjC-3v76A:18.54"],["2JKJ_E_CLME1141_0","DR HEMAGGLUTININ STRUCTURAL SUBUNIT","3v76","FLAVOPROTEIN","Sinorhizobium meliloti",4,"PRO A  40;GLY A  14;ILE A  10;GLY A  12","None;FDA A 547 (-3.4A);None;FDA A 547 (-3.4A)","0.74A","2jkjE-3v76A:undetectable","2jkjE-3v76A:18.54"],["2JKL_A_CLMA1144_0","DR HEMAGGLUTININ STRUCTURAL SUBUNIT","3v76","FLAVOPROTEIN","Sinorhizobium meliloti",4,"PRO A  40;GLY A  14;ILE A  10;GLY A  12","None;FDA A 547 (-3.4A);None;FDA A 547 (-3.4A)","0.78A","2jklA-3v76A:undetectable","2jklA-3v76A:18.54"],["2JKL_B_CLMB1144_0","DR HEMAGGLUTININ STRUCTURAL SUBUNIT","3v76","FLAVOPROTEIN","Sinorhizobium meliloti",4,"PRO A  40;GLY A  14;ILE A  10;GLY A  12","None;FDA A 547 (-3.4A);None;FDA A 547 (-3.4A)","0.79A","2jklB-3v76A:undetectable","2jklB-3v76A:18.54"],["2JKL_C_CLMC1143_0","DR HEMAGGLUTININ STRUCTURAL SUBUNIT","3v76","FLAVOPROTEIN","Sinorhizobium meliloti",4,"PRO A  40;GLY A  14;ILE A  10;GLY A  12","None;FDA A 547 (-3.4A);None;FDA A 547 (-3.4A)","0.81A","2jklC-3v76A:undetectable","2jklC-3v76A:18.54"],["2JKL_D_CLMD1145_0","DR HEMAGGLUTININ STRUCTURAL SUBUNIT","3v76","FLAVOPROTEIN","Sinorhizobium meliloti",4,"PRO A  40;GLY A  14;ILE A  10;GLY A  12","None;FDA A 547 (-3.4A);None;FDA A 547 (-3.4A)","0.79A","2jklD-3v76A:undetectable","2jklD-3v76A:18.54"],["2JKL_E_CLME1143_0","DR HEMAGGLUTININ STRUCTURAL SUBUNIT","3v76","FLAVOPROTEIN","Sinorhizobium meliloti",4,"PRO A  40;GLY A  14;ILE A  10;GLY A  12","None;FDA A 547 (-3.4A);None;FDA A 547 (-3.4A)","0.78A","2jklE-3v76A:undetectable","2jklE-3v76A:18.54"],["2JKL_F_CLMF1143_0","DR HEMAGGLUTININ STRUCTURAL SUBUNIT","3v76","FLAVOPROTEIN","Sinorhizobium meliloti",4,"PRO A  40;GLY A  14;ILE A  10;GLY A  12","None;FDA A 547 (-3.4A);None;FDA A 547 (-3.4A)","0.79A","2jklF-3v76A:undetectable","2jklF-3v76A:18.54"],["2V0M_B_KLNB1498_1","CYTOCHROME P450 3A4","3v76","FLAVOPROTEIN","Sinorhizobium meliloti",5,"LEU A 193;ALA A 240;GLU A 252;GLY A 331;LEU A 196","None","1.13A","2v0mB-3v76A:undetectable","2v0mB-3v76A:21.90"],["2YVL_A_SAMA601_0","HYPOTHETICAL PROTEIN","3v76","FLAVOPROTEIN","Sinorhizobium meliloti",5,"GLY A 414;GLY A 410;SER A 409;ALA A  75;ALA A  21","None","0.94A","2yvlA-3v76A:3.1","2yvlA-3v76A:21.04"],["2ZIF_A_SAMA298_0","PUTATIVE MODIFICATION METHYLASE","3v76","FLAVOPROTEIN","Sinorhizobium meliloti",5,"ALA A 406;PRO A 167;GLY A 163;THR A 172;GLU A 368","FDA A 547 ( 3.7A);None;None;FDA A 547 (-3.1A);FDA A 547 (-4.1A)","1.20A","2zifA-3v76A:undetectable","2zifA-3v76A:22.33"],["3CKK_A_SAMA301_0","TRNA (GUANINE-N(7)-)-METHYLTRANSFERASE","3v76","FLAVOPROTEIN","Sinorhizobium meliloti",5,"GLY A 162;GLY A 163;GLU A 368;ALA A  16;LEU A 174","FDA A 547 (-3.4A);None;FDA A 547 (-4.1A);FDA A 547 (-3.5A);FDA A 547 (-3.8A)","1.14A","3ckkA-3v76A:2.5","3ckkA-3v76A:20.24"],["3JB1_A_SAMA1101_0","STRUCTURAL PROTEIN VP3","3v76","FLAVOPROTEIN","Sinorhizobium meliloti",5,"ILE A  11;GLY A  12;ASP A  35;ALA A  37;ALA A  16","None;FDA A 547 (-3.4A);FDA A 547 (-3.1A);FDA A 547 ( 3.9A);FDA A 547 (-3.5A)","0.98A","3jb1A-3v76A:undetectable","3jb1A-3v76A:17.41"],["3MG0_H_BO2H1400_1","PROTEASOME COMPONENT PUP1;PROTEASOME COMPONENT PUP3","3v76","FLAVOPROTEIN","Sinorhizobium meliloti",5,"THR A 131;ALA A 149;GLY A 150;THR A 151;ASP A 153","None","1.14A","3mg0H-3v76A:undetectable;3mg0I-3v76A:undetectable","3mg0H-3v76A:19.76;3mg0I-3v76A:19.52"],["3Q70_A_RITA2001_2","CANDIDAPEPSIN-2","3v76","FLAVOPROTEIN","Sinorhizobium meliloti",4,"THR A 341;SER A 161;ILE A 178;THR A 373","None;FDA A 547 (-4.8A);None;None","1.09A","3q70A-3v76A:undetectable","3q70A-3v76A:21.04"],["3QXY_A_SAMA6734_0","N-LYSINE METHYLTRANSFERASE SETD6","3v76","FLAVOPROTEIN","Sinorhizobium meliloti",5,"VAL A 159;ALA A 160;GLY A  12;ALA A  24;LEU A 363","None;None;FDA A 547 (-3.4A);None;None","1.11A","3qxyA-3v76A:undetectable","3qxyA-3v76A:23.38"],["3RC0_A_SAMA484_0","N-LYSINE METHYLTRANSFERASE SETD6","3v76","FLAVOPROTEIN","Sinorhizobium meliloti",5,"VAL A 159;ALA A 160;GLY A  12;ALA A  24;LEU A 363","None;None;FDA A 547 (-3.4A);None;None","1.11A","3rc0A-3v76A:undetectable","3rc0A-3v76A:23.38"],["3RC0_B_SAMB480_0","N-LYSINE METHYLTRANSFERASE SETD6","3v76","FLAVOPROTEIN","Sinorhizobium meliloti",5,"VAL A 159;ALA A 160;GLY A  12;ALA A  24;LEU A 363","None;None;FDA A 547 (-3.4A);None;None","1.12A","3rc0B-3v76A:undetectable","3rc0B-3v76A:23.38"],["3SUD_A_SUEA1201_1","NS3 PROTEASE, NS4A PROTEIN","3v76","FLAVOPROTEIN","Sinorhizobium meliloti",6,"GLY A  17;GLY A 367;ALA A 406;ALA A 408;ALA A  75;SER A  74","None;FDA A 547 (-3.5A);FDA A 547 ( 3.7A);None;None;None","1.43A","3sudA-3v76A:undetectable","3sudA-3v76A:20.68"],["4DA7_A_AC2A301_1","PURINE NUCLEOSIDE PHOSPHORYLASE DEOD-TYPE","3v76","FLAVOPROTEIN","Sinorhizobium meliloti",5,"MET A 120;GLY A 410;ALA A  24;GLU A  23;VAL A 366","None","0.86A","4da7A-3v76A:undetectable","4da7A-3v76A:22.90"],["4F4D_A_CHDA505_0","FERROCHELATASE, MITOCHONDRIAL","3v76","FLAVOPROTEIN","Sinorhizobium meliloti",4,"MET A  19;ARG A  27;VAL A 417;MET A 355","None","1.37A","4f4dA-3v76A:undetectable","4f4dA-3v76A:21.08"],["4QVP_H_BO2H301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","3v76","FLAVOPROTEIN","Sinorhizobium meliloti",5,"THR A 131;ALA A 149;GLY A 150;THR A 151;ASP A 153","None","1.23A","4qvpH-3v76A:undetectable;4qvpI-3v76A:undetectable","4qvpH-3v76A:20.00;4qvpI-3v76A:19.76"],["4QVP_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","3v76","FLAVOPROTEIN","Sinorhizobium meliloti",5,"THR A 131;ALA A 149;GLY A 150;THR A 151;ASP A 153","None","1.24A","4qvpV-3v76A:undetectable;4qvpW-3v76A:undetectable","4qvpV-3v76A:20.00;4qvpW-3v76A:19.76"],["4QVY_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","3v76","FLAVOPROTEIN","Sinorhizobium meliloti",5,"THR A 131;ALA A 149;GLY A 150;THR A 151;ASP A 153","None","1.24A","4qvyV-3v76A:undetectable;4qvyW-3v76A:undetectable","4qvyV-3v76A:20.00;4qvyW-3v76A:19.76"],["4QW0_H_BO2H301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","3v76","FLAVOPROTEIN","Sinorhizobium meliloti",5,"THR A 131;ALA A 149;GLY A 150;THR A 151;ASP A 153","None","1.23A","4qw0H-3v76A:undetectable;4qw0I-3v76A:undetectable","4qw0H-3v76A:20.00;4qw0I-3v76A:19.76"],["4QW0_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","3v76","FLAVOPROTEIN","Sinorhizobium meliloti",5,"THR A 131;ALA A 149;GLY A 150;THR A 151;ASP A 153","None","1.22A","4qw0V-3v76A:undetectable;4qw0W-3v76A:undetectable","4qw0V-3v76A:20.00;4qw0W-3v76A:19.76"],["4QW1_H_BO2H301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","3v76","FLAVOPROTEIN","Sinorhizobium meliloti",5,"THR A 131;ALA A 149;GLY A 150;THR A 151;ASP A 153","None","1.23A","4qw1H-3v76A:undetectable;4qw1I-3v76A:undetectable","4qw1H-3v76A:20.00;4qw1I-3v76A:19.76"],["4QW1_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","3v76","FLAVOPROTEIN","Sinorhizobium meliloti",5,"THR A 131;ALA A 149;GLY A 150;THR A 151;ASP A 153","None","1.23A","4qw1V-3v76A:undetectable;4qw1W-3v76A:undetectable","4qw1V-3v76A:20.00;4qw1W-3v76A:19.76"],["4V20_A_ACTA1444_0","CELLOBIOHYDROLASE","3v76","FLAVOPROTEIN","Sinorhizobium meliloti",4,"GLY A 163;THR A 341;GLY A 344;GLU A 368","None;None;None;FDA A 547 (-4.1A)","1.18A","4v20A-3v76A:undetectable","4v20A-3v76A:22.24"],["4X30_A_T44A401_1","THYROXINE-BINDING GLOBULIN","3v76","FLAVOPROTEIN","Sinorhizobium meliloti",5,"ALA A 216;GLN A 202;LEU A 198;LEU A 256;LEU A 236","None","1.43A","4x30A-3v76A:undetectable","4x30A-3v76A:21.28"],["4X30_A_T44A401_1","THYROXINE-BINDING GLOBULIN","3v76","FLAVOPROTEIN","Sinorhizobium meliloti",5,"ALA A 240;GLN A 202;LEU A 198;LEU A 256;LEU A 236","None","1.30A","4x30A-3v76A:undetectable","4x30A-3v76A:21.28"],["5BXN_H_BO2H301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","3v76","FLAVOPROTEIN","Sinorhizobium meliloti",5,"THR A 131;ALA A 149;GLY A 150;THR A 151;ASP A 153","None","1.18A","5bxnH-3v76A:undetectable;5bxnI-3v76A:undetectable","5bxnH-3v76A:21.12;5bxnI-3v76A:19.76"],["5BXN_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","3v76","FLAVOPROTEIN","Sinorhizobium meliloti",5,"THR A 131;ALA A 149;GLY A 150;THR A 151;ASP A 153","None","1.18A","5bxnV-3v76A:undetectable;5bxnW-3v76A:undetectable","5bxnV-3v76A:21.12;5bxnW-3v76A:19.76"],["5CZ7_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","3v76","FLAVOPROTEIN","Sinorhizobium meliloti",5,"THR A 131;ALA A 149;GLY A 150;THR A 151;ASP A 153","None","1.23A","5cz7V-3v76A:undetectable;5cz7W-3v76A:undetectable","5cz7V-3v76A:20.00;5cz7W-3v76A:19.76"],["5E3I_A_HISA502_0","HISTIDINE--TRNA LIGASE","3v76","FLAVOPROTEIN","Sinorhizobium meliloti",5,"GLU A 368;THR A 341;TYR A 176;GLY A 173;ALA A 171","FDA A 547 (-4.1A);None;None;None;None","1.21A","5e3iA-3v76A:undetectable","5e3iA-3v76A:24.51"],["5E3I_B_HISB502_0","HISTIDINE--TRNA LIGASE","3v76","FLAVOPROTEIN","Sinorhizobium meliloti",5,"GLU A 368;THR A 341;TYR A 176;GLY A 173;ALA A 171","FDA A 547 (-4.1A);None;None;None;None","1.23A","5e3iB-3v76A:undetectable","5e3iB-3v76A:24.51"],["5L5F_H_BO2H301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","3v76","FLAVOPROTEIN","Sinorhizobium meliloti",5,"THR A 131;ALA A 149;GLY A 150;THR A 151;ASP A 153","None","1.23A","5l5fH-3v76A:undetectable;5l5fI-3v76A:undetectable","5l5fH-3v76A:20.00;5l5fI-3v76A:19.76"],["5L5F_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","3v76","FLAVOPROTEIN","Sinorhizobium meliloti",5,"THR A 131;ALA A 149;GLY A 150;THR A 151;ASP A 153","None","1.23A","5l5fV-3v76A:undetectable;5l5fW-3v76A:undetectable","5l5fV-3v76A:20.00;5l5fW-3v76A:19.76"],["5L66_H_BO2H301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","3v76","FLAVOPROTEIN","Sinorhizobium meliloti",5,"THR A 131;ALA A 149;GLY A 150;THR A 151;ASP A 153","None","1.22A","5l66H-3v76A:undetectable;5l66I-3v76A:undetectable","5l66H-3v76A:20.00;5l66I-3v76A:19.76"],["5L66_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","3v76","FLAVOPROTEIN","Sinorhizobium meliloti",5,"THR A 131;ALA A 149;GLY A 150;THR A 151;ASP A 153","None","1.23A","5l66V-3v76A:undetectable;5l66W-3v76A:undetectable","5l66V-3v76A:20.00;5l66W-3v76A:19.76"],["6FOS_A_PQNA2001_1","PHOTOSYSTEM I P700 CHLOROPHYLL A APOPROTEIN A1","3v76","FLAVOPROTEIN","Sinorhizobium meliloti",4,"MET A  18;GLY A  12;ALA A  37;LEU A 129","None;FDA A 547 (-3.4A);FDA A 547 ( 3.9A);None","1.06A","6fosA-3v76A:undetectable","6fosA-3v76A:11.17"]]